Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System
Thursday, Abbott Laboratories (NYSE:ABT) said it is recalling some FreeStyle Libre 3 sensors after finding ... Continuous ...
2 Excellent Dividend Stocks to Buy With Less Than $200
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
AOL19d
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
In June, Abbott Laboratories announced that the U.S. Food and Drug Administration (FDA) had cleared the Libre Rio, a new over-the-counter (OTC) CGM option for type 2 diabetes patients who do not ...
stocknews3d
3 MedTech Stocks to Watch as Innovation in Healthcare Soars
MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in ...
Down More Than 50%, Is DexCom Stock a Bargain Now?
DexCom markets one of the world's most popular constant blood glucose monitors (CGM). These discreet devices adhere to the ...
The Motley Fool19d
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...
AOL7d
2 Excellent Dividend Stocks to Buy With Less Than $200
Abbott Laboratories is a healthcare giant with products ... In recent years, its FreeStyle Libre franchise of continuous glucose monitoring (CGM) systems -- which help diabetics keep track of ...
Yahoo Finance1mon
Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System
Thursday, Abbott Laboratories (NYSE:ABT) said it is recalling some FreeStyle Libre 3 sensors after finding that a small ... Dexcom’s Stelo Device Brings Affordable Continuous Glucose Monitoring To ...